Combating Illicit Xylazine Act
[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 1266 Introduced in House (IH)] <DOC> 119th CONGRESS 1st Session H. R. 1266 To prohibit certain uses of xylazine, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES February 12, 2025 Mr. Panetta (for himself, Mr. Pfluger, Mr. Bilirakis, Mr. Pappas, Mr. Fitzgerald, Ms. Ross, Mr. Crenshaw, Mr. Harder of California, Ms. DelBene, Mrs. Miller-Meeks, Ms. Pettersen, Ms. Clarke of New York, Mr. Deluzio, Mr. Magaziner, Mr. Bacon, Mr. Obernolte, Mr. Costa, Mr. Balderson, Ms. Barragan, Mr. Ciscomani, Mr. Carey, Mrs. Bice, Ms. Craig, Mr. Norcross, Mr. Fong, Ms. Tenney, Mr. Fitzpatrick, Mr. Burchett, Ms. Dean of Pennsylvania, Mr. Cohen, Mr. Davis of North Carolina, Mr. Correa, Mr. Webster of Florida, Mr. Collins, Mr. Suozzi, and Mrs. Harshbarger) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned _______________________________________________________________________ A BILL To prohibit certain uses of xylazine, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This title may be cited as the ``Combating Illicit Xylazine Act''. SEC. 2. DEFINITIONS. (a) In General.--In this title, the term ``xylazine'' has the meaning given the term in paragraph (60) of section 102 of the Controlled Substances Act, as added by subsection (b) of this section. (b) Controlled Substances Act.--Section 102 of the Controlled Substances Act (21 U.S.C. 802) is amended by adding at the end the following: ``(60) The term `xylazine' means the substance xylazine, including its salts, iso
Consumer affairs
Crime and Law Enforcement
Congressional oversight
Criminal procedure and sentencing
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Licensing and registrations
Manufacturing
U.S. Sentencing Commission
Veterinary medicine and animal diseases
← Back to Mark Alford's profile